Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy

Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy

The aim of this work to evaluate the accuracy of contrast enhanced spectral mamography in predicting the response to NAC and assessment of residual disease in breast cancer patients

This a prospective series ,will be performed for 50 patients diagnosed by biopsy as breast cancer who will be scheduled for surgery after completing the full coarse of neoadjuvant chemotherapy

Inclusion Criteria:

• patient confirmed diagnosed by early breast cancer decided to received neoadjuvant treatment
• locally advanced breast cancer
• operable metastatic breast cancer

Exclusion Criteria:

• patient not candidate for NAC
• contrast allergy
• renal impairment
• pregnancy